Skip to main content

Want a detailed portfolio tracker?

Prometheus Biosciences (RXDX) EBITDA (2021 - 2023)

Prometheus Biosciences (RXDX) EBITDA from Mar 31, 2021 to Mar 31, 2023. The TTM Prometheus Biosciences (RXDX) EBITDA is -$155M. You can adjust inflation or export chart.

Annual EBITDA

Quarterly EBITDA

Prometheus Biosciences (RXDX) EBITDA CAGR table

PeriodCAGR
1 Year TTM-11.47%

Annual EBITDA change of Prometheus Biosciences (RXDX)

YearEBITDAChange
2023-$48M-66.61%
2022-$145M+65.81%
2021-$88MN/A